BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16636266)

  • 1. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
    Schlegel U; Jürgens A; Pels H
    Neurology; 2006 Apr; 66(8):1287; author reply 1287. PubMed ID: 16636266
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
    Küker W; Nägele T; Thiel E; Weller M; Herrlinger U
    Neurology; 2005 Oct; 65(7):1129-31. PubMed ID: 16217075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant lymphoma in the central nervous system: overview].
    Namekawa M
    Brain Nerve; 2014 Aug; 66(8):907-16. PubMed ID: 25082313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
    Kiewe P; Fischer L; Martus P; Thiel E; Korfel A
    Cancer; 2008 Apr; 112(8):1812-20. PubMed ID: 18318432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic problems in case of primary central nervous system lymphoma].
    Dubik-Jezierzańska M; Pokryszko-Dragan A; Turek T; Budrewicz S; Pawlik B
    Wiad Lek; 2006; 59(7-8):552-6. PubMed ID: 17209358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary central nervous system lymphoma: an update.
    Soussain C; Hoang-Xuan K
    Curr Opin Oncol; 2009 Nov; 21(6):550-8. PubMed ID: 19684518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
    Green MR; Chowdhary S; Lombardi KM; Chalmers LM; Chamberlain M
    Expert Rev Neurother; 2006 May; 6(5):635-52. PubMed ID: 16734512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
    Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of lymphoma of the central nervous system, spine, and orbit.
    Haque S; Law M; Abrey LE; Young RJ
    Radiol Clin North Am; 2008 Mar; 46(2):339-61, ix. PubMed ID: 18619384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary central nervous system lymphoma.
    Mohile NA; Abrey LE
    Semin Radiat Oncol; 2007 Jul; 17(3):223-9. PubMed ID: 17591569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system lymphomas: salvage treatment after failure to high-dose methotrexate.
    Reni M; Mazza E; Foppoli M; Ferreri AJ
    Cancer Lett; 2007 Dec; 258(2):165-70. PubMed ID: 17993246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma.
    Momota H; Narita Y; Maeshima AM; Miyakita Y; Shinomiya A; Maruyama T; Muragaki Y; Shibui S
    J Neurooncol; 2010 Jul; 98(3):341-8. PubMed ID: 20012911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual uterine recurrence of primary central nervous system lymphoma.
    Nichols GL; Jacobson CA; Ferman D; Lichtman SM
    Clin Adv Hematol Oncol; 2006 Sep; 4(9):697-8, discussion 699-700. PubMed ID: 17099627
    [No Abstract]   [Full Text] [Related]  

  • 14. [A 36-year-old woman with primary central nervous system lymphoma diagnosed by twice brain biopsies, showing relapsing and remitting brain lesions].
    Takasone K; Kobayashi C; Katoh N; Kaneko T; Shingu K; Ikeda SI
    Rinsho Shinkeigaku; 2018 Jul; 58(7):440-444. PubMed ID: 29962441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary central nervous system lymphoma in a renal transplant recipient with Bardet-Biedl syndrome.
    Ersoy A; Kahvecioglu S; Bekar A; Aker S; Akdag I; Dilek K
    Transplant Proc; 2005 Dec; 37(10):4323-5. PubMed ID: 16387110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary lymphoma of the central nervous system: 20 years' experience in a referral hospital].
    Calderón-Garcidueñas AL; Pacheco-Calleros J; Castelán-Maldonado E; Nocedal-Rustrián FC
    Rev Neurol; 2008 Jan 16-31; 46(2):84-8. PubMed ID: 18247279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K; Thiel E
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and diagnosis of primary central nervous system lymphoma.
    Fitzsimmons A; Upchurch K; Batchelor T
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):689-703, vii. PubMed ID: 16083830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in primary central nervous system lymphomas.
    Ferreri AJ; Reni M
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):629-49, vi. PubMed ID: 16083827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of diagnosis and treatment for primary central nervous system lymphoma].
    Meng FG; Zhang K; Mao GS; Wang ZC; Wu CY; Liu K
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1549-52. PubMed ID: 18282393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.